Buy Sibelium
Sibelium

0.6
Sibelium (flunarizine) is a calcium channel blocker used primarily for the prophylactic treatment of migraines and the management of vestibular disorders. By preventing the narrowing of blood vessels and protecting nerve cells, it reduces the frequency of migraine attacks and symptoms of dizziness.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Flunarizine
Reference Brand
Sibelium
Manufacturer
Janssen-Cilag
Product Form
Capsules, Tablets
Regulatory Classification
Rx
Primary Category
Migraine Prevention
Product Category
Nervous system, Antimigraine preparations, Other antimigraine preparations
Pharmacological Class
Calcium Channel Blocker
Manufacturer Description
A preventative medicine taken daily to reduce the frequency and severity of migraine attacks.
Mechanism of Action
Flunarizine prevents calcium overload in cells, which helps reduce the narrowing and widening of blood vessels and protects nerve cells. This helps reduce the frequency of migraine attacks.
Route of Administration
Oral
Onset Time
Several weeks (up to 2 months)
Duration
Ongoing prevention
Contraindications
History of depressive illness, Parkinson's disease, Extrapyramidal disorders
Severe Adverse Events
Parkinsonism (tremor, stiffness), Severe depression, Restlessness (akathisia)
Common Side Effects
Increased appetite, Weight gain, Drowsiness
Uncommon Side Effects
Insomnia, Fatigue, Nausea
Drug Interactions
Alcohol, Sleeping pills, Oral contraceptives
Pregnancy Safety Warnings
Avoid during pregnancy unless absolutely necessary.
Age Restrictions
Adults (usually up to 65 years)
Storage Guidelines
Store at room temperature.

Sibelium FAQ

Can I travel internationally with Sibelium?

Yes, Sibelium can be taken while travelling, but keep the medication in its original packaging with the prescription label visible. In the UK, the MHRA advises carrying a copy of the prescription and a letter from your doctor if you are traveling to countries with strict drug import rules.

Will Sibelium affect my ability to drive or operate machinery?

Sibelium may cause drowsiness, especially when you first start treatment. It is advisable to assess your reaction to the medication before driving or using heavy machinery. If you notice impairment, avoid such activities until you are certain the drug does not affect you.

What does the imprint on a Sibelium pill look like?

The 5 mg tablet is typically imprinted with “SIB 5”, while the 10 mg tablet carries “SIB 10”. Imprints can vary slightly between manufacturers, so always verify the appearance against the pharmacy label.

Are there any dietary restrictions while taking Sibelium?

No specific food interactions are known. However, consuming large amounts of grapefruit or grapefruit juice can inhibit CYP3A4 metabolism and potentially increase flunarizine levels, so moderation is recommended.

How does Sibelium compare with other migraine preventatives like propranolol?

Both flunarizine and propranolol are effective migraine prophylactics, but they act via different mechanisms-flunarizine blocks calcium channels while propranolol is a beta-blocker. Choice of therapy depends on individual patient factors, comorbidities, and side-effect profiles, and should be discussed with a clinician.

Is Sibelium safe for people with depression?

Flunarizine can exacerbate depressive symptoms in susceptible individuals. If you have a history of depression, your prescriber will monitor mood closely and may consider alternative preventive treatments.

Can Sibelium be used for tension-type headaches?

Current evidence does not support routine use of flunarizine for tension-type headaches, and it is not an approved indication in the UK. Off-label use should only occur after a specialist assessment.

What should I do if I miss a dose while traveling across time zones?

Take the missed dose as soon as you remember, provided it is not close to the time of your next scheduled dose. If the next dose is due within a few hours, skip the missed one and continue with your regular schedule. Do not double-dose.

How long does it typically take to notice a reduction in migraine frequency?

Most patients report a noticeable decrease in migraine days after 4-6 weeks of consistent therapy at the therapeutic dose. Full benefit may take up to 12 weeks for some individuals.

Is there a generic version of Sibelium available in the UK?

Yes, flunarizine is also marketed as a generic pill in the UK. Generic formulations contain the same active ingredient and are prescribed in the same 5 mg and 10 mg strengths.

What is Sibelium?

Sibelium is a prescription medication that contains flunarizine as its sole active ingredient. Flunarizine is a calcium-channel-blocking agent that belongs to the neurology class of drugs. In the United Kingdom Sibelium is supplied as a pill and is available in 5 mg and 10 mg strengths. The product is prescribed under the supervision of a qualified prescriber and is regulated by the UK Medicines and Healthcare products Regulatory Agency (MHRA). It is marketed in the UK by Sanofi.

How Sibelium Works in the Body

Flunarizine reduces the flow of calcium ions into nerve cells by blocking voltage-gated calcium channels. This action:

  • Decreases neuronal excitability, which helps to prevent the electrical disturbances that trigger migraine attacks.
  • Inhibits the release of excitatory neurotransmitters such as glutamate.
  • Dampens the phenomenon known as cortical spreading depression, a wave of neuronal depolarisation that underlies migraine aura.

Flunarizine also has antihistamine properties and modest affinity for sigma-1 receptors, which may contribute to its effectiveness in certain vestibular (balance-related) disorders.

The drug is well absorbed after oral ingestion, reaching peak plasma concentrations within 2-4 hours. It is extensively metabolised in the liver and eliminated primarily via the bile.

Conditions Treated by Sibelium

Sibelium is officially approved in the UK for:

  • Migraine prophylaxis - prevention of recurrent migraine attacks in adults.
  • Management of vertigo and other vestibular disorders - especially when symptoms are recurrent or disabling.

These indications are based on the drug’s ability to stabilise neuronal firing in the brainstem and cerebellum, areas involved in balance and headache generation.

Evidence-Based Off-Label Uses

Research published in peer-reviewed journals has explored additional applications of flunarizine, though they remain off-label in the UK:

  • Vestibular migraine - small randomised trials suggest that flunarizine can reduce the frequency of migraine-related vertigo episodes.
  • Cluster headache prophylaxis - case series have reported benefit, but larger controlled studies are lacking.

Off-label use of Sibelium requires careful medical supervision and a thorough risk-benefit assessment.

Who Should (Not) Use Sibelium?

Absolute Contraindications

  • Known hypersensitivity to flunarizine or any of the pill’s excipients.
  • Pregnancy (category X) and breastfeeding - flunarizine can cross the placenta and is excreted in milk.
  • Severe hepatic impairment - the drug’s metabolism is compromised.

Relative Contraindications / Cautions

  • Mild-to-moderate liver disease - dose may need adjustment.
  • Renal impairment - monitor for accumulation, especially in the elderly.
  • Depressive disorders or a history of suicidal thoughts - flunarizine can exacerbate mood changes.
  • Parkinsonian syndromes or other extrapyramidal disorders - the medication may worsen motor symptoms.
  • Elderly patients - increased susceptibility to drowsiness, weight gain, and falls.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Weight gain - reported in up to 10 % of users; gradual monitoring is advised.
  • Drowsiness or fatigue - often improves after the first few weeks.
  • Dry mouth and mild gastro-intestinal discomfort.
  • Depressive symptoms - mood changes may appear early; patients should be counselled to report persistent sadness or anxiety.

Serious Adverse Events

  • Severe depression or suicidal ideation - requires immediate medical attention.
  • Extrapyramidal reactions (e.g., tremor, rigidity, parkinsonian features).
  • Hypotension - rare but possible, especially when combined with other vasodilators.

Drug Interactions

  • CYP3A4 inhibitors (e.g., erythromycin, ketoconazole, grapefruit juice) can raise flunarizine plasma levels → increase side-effect risk.
  • Other calcium-channel blockers (e.g., amlodipine) - additive cardiovascular effects, monitor blood pressure.
  • Central nervous system depressants (e.g., benzodiazepines, alcohol) - may enhance sedation.

Food and Lifestyle Interactions

  • No specific food restrictions, but alcohol should be limited due to additive drowsiness.
  • Patients should avoid operating heavy machinery until they know how Sibelium affects them.

If you are taking other medicines, supplements, or herbal products, inform your prescriber before starting Sibelium.

How to Take Sibelium

  • Standard dosing:

  • Begin with 5 mg once daily, usually taken in the evening.

  • If migraine control is inadequate after 7-10 days, the dose may be increased to 10 mg once daily.

  • The maximum recommended dose is 10 mg per day.

  • Special populations:

  • Elderly - start at 5 mg and assess tolerance before any increase.

  • Liver impairment - consider a reduced dose (5 mg) and monitor liver function tests.

  • Administration: Swallow the pill whole with water; it may be taken with or without food.

  • Missed dose: Take the missed dose as soon as you remember, unless it is close to the time of the next scheduled dose. Do not double the dose.

  • Overdose: Symptoms may include extreme drowsiness, low blood pressure, and nausea. Seek emergency medical care; supportive measures are the mainstay of treatment.

  • Discontinuation: Do not stop abruptly if you have been on Sibelium for several weeks. Tapering (e.g., reducing to 5 mg for a week before stopping) can minimise rebound headache and withdrawal effects.

Monitoring and Follow-Up

  • Baseline assessment of mood, weight, and liver function before starting therapy.
  • Follow-up visits after 4-6 weeks to evaluate migraine frequency, side-effects, and weight change.
  • Laboratory testing: liver enzymes (ALT, AST) every 3-6 months in patients with hepatic risk factors.
  • Neurological review: monitor for any signs of extrapyramidal symptoms or worsening of movement disorders.

If any serious side effect develops, contact a healthcare professional promptly.

Storage and Handling

  • Keep the bottle tightly closed, stored at room temperature (≤ 30 °C), away from moisture and direct sunlight.
  • Keep out of reach of children and pets.
  • Do not use the medication after the expiry date printed on the packaging.
  • For disposal, follow the NHS guidance on safe medicine disposal (e.g., return to a pharmacy’s medicine-take-back scheme).

Medication-Specific Glossary

Calcium-Channel Blocker
A drug that inhibits the entry of calcium ions into cells, reducing neuronal excitability and vascular smooth-muscle contraction.
Cortical Spreading Depression
A wave of neuronal depolarisation that moves across the cerebral cortex and is thought to trigger migraine aura and headache pain.
Extrapyramidal Symptoms
Drug-induced movement disorders such as tremor, rigidity, bradykinesia, or dystonia, resulting from interference with dopaminergic pathways.
Sigma-1 Receptor
A protein located in the endoplasmic reticulum that modulates ion channels and neurotransmitter release; flunarizine’s modest affinity may influence its therapeutic profile.

Medical Disclaimer

This article provides educational information about Sibelium and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Sibelium is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories
Waar kunt u Spierontspanners & Ontstekingsremmers bestellen - Baclofen online iDeal Order medications for Insomnia Treatment Hong Kong: - Zaleplon Price